Background: Native T 1 mapping has emerged as a noninvasive non-contrast magnetic resonance imaging (MRI) method to assess for diffuse myocardial fibrosis. However, LV native T 1 time in AF patients and its clinical relevance are unclear. Methods: Fifty paroxysmal AF patients referred for PVI (60 ± 8 years, 37 male) and 11 healthy control subjects (57 ± 8 years, 10 male) were studied. All patients were in sinus rhythm during the MRI scan. Native T 1 mapping images were acquired using a Modified Look-Locker imaging (MOLLI) sequence in 3 short-axis planes (basal, mid and apical slices) using an electrocardiogram triggered single-shot acquisition with a balanced steadystate free precession readout. Late gadolinium enhanced (LGE) MRI was acquired to evaluate for LV myocardial scar. Results: LV ejection fraction was similar between groups (AF: 61 ± 6%; controls: 60 ± 6%, p = 0.75). No LV myocardial scar was observed in any patient on LGE. Myocardial native T 1 time was greater in AF patients (1099 ± 52 vs 1042 ± 20 msec, p b 0.001). During a median follow-up period of 326 days, 18 of 50 (36%) patients experienced recurrence of AF. Multivariate Cox proportional hazard analysis identified elevated native T 1 time as an independent predictor of recurrence of AF (HR: 6.53, 95% CI: 1.25-34.3, p = 0.026). Conclusions: There are differences in the native LV myocardial T 1 time between AF patients with preserved LV function referred for PVI and normal controls. Native T 1 time is an independent predictor of recurrence of AF after PVI in patients with paroxysmal AF.
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Background
Atrial fibrillation (AF) is the most common sustained arrhythmia, affecting 2% for those b 65 years and 9% of those ≥ 65 years in the United States [1] . The symptoms of AF vary greatly, ranging from minimal to severe disability. AF is associated with a 5-fold increased risk of stroke [2] and a 3-fold increased risk of heart failure [3] [4] [5] . In AF patients, diffuse myocardial interstitial fibrosis may occur due to tachycardia induced cardiomyopathy [6] . Previous studies demonstrated that tachycardia induced cardiomyopathy may progress to heart failure and lethal ventricular arrhythmia in AF patients [7] [8] [9] . Therefore, detection of underlying LV myocardial abnormalities in AF patients is essential for clinical management.
Native T 1 mapping has been introduced as a robust magnetic resonance imaging (MRI) technique for the assessment of diffuse myocardial fibrosis in various cardiovascular disease. Recent studies has demonstrated that native T 1 mapping detects left ventricular (LV) myocardial abnormalities in patients with hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) [10] , cardiac amyloidosis [11] and Anderson-Fabry disease [11, 12] . Native T 1 mapping could be useful to assess the extent of myocardial injury by acute myocardial infarction [13] . To the best of our knowledge, no data are available regarding LV native T 1 time in AF patients. We hypothesized that native T 1 mapping could detect the subclinical LV myocardial abnormality in AF patients.
Therefore, we sought to compare native myocardial T 1 time by using a modified Look-Locker inversion recovery (MOLLI) sequence in patients with AF and healthy control subjects; and to investigate whether native T 1 time can predict the recurrence of AF after their first pulmonary vein isolation (PVI) in patients with paroxysmal AF.
Materials and methods

Study subjects
Inclusion criteria of this prospective study included a history of paroxysmal AF patients referred for their first PVI. Exclusion criteria included patients in AF during MRI scan, reduced LV systolic function (LVEF b 50%) [14] , cardiomyopathy (HCM, DCM [15] ), cardiac sarcoidosis and amyloidosis, severe valvular heart disease, prior myocardial infarction and contraindication to MRI examination (claustrophobia, pacemaker implantation etc.). According to this criteria, we enrolled 50 paroxysmal AF patients. Eleven subjects without any history of cardiovascular diseases including AF were recruited as healthy controls.
Acquisition of MRI
All MRI data were acquired using a 1.5-T MRI system and a 32-channel cardiac phased array receiver coil (Achieva, Philips Healthcare, Best, The Netherlands). The study protocol was approved by our institutional review board, and written informed consent was obtained from all study subjects. Cine MRI, T 1 mapping and 3 dimensional late gadolinium enhancement (LGE) MRI were imaged in all participants. T 1 mapping of LV myocardium was performed using a MOLLI sequence [16] .
Cine MRI acquisition
Electrocardiogram (ECG) monitoring leads were positioned on supine patients. Vertical and horizontal long-axis cine MRI images of the LV were acquired using a steady-state free precession (SSFP) sequence. LV volumes and mass were calculated from an LV short-axis stack of cine images extending from the apex to the base (repetition time (TR), 3.3 ms; echo time (TE), 1.6 ms; flip angle (FA), 60°; field-of-view (FOV), 320 × 320 mm; acquisition matrix, 128 × 128; slice thickness, 8 mm; gap, 2 mm).
Native T 1 mapping by MOLLI
T 1 mapping images of LV myocardium were acquired in 3 shortaxis planes (basal, mid and apical). Images were acquired during an end-expiration breath-hold using an ECG-triggered single-shot acquisition with a balanced SSFP readout (TR, 3.1 ms; TE, 1.5 ms; FA, 35°; FOV, 360 × 337 mm 2 ; acquisition matrix, 188 × 135; voxel size, 1.9 × 2.5 mm 2 ; slice thickness, 8 mm).
Late gadolinium enhancement
Fifteen minutes after the injection of 0.2 mmol/kg gadobenate dimeglumine (MultiHance; Bracco, Rome, Italy), LGE images were acquired using a 3 dimensional sequence [17] (TR, 5.3 ms; TE, 2.1 ms; FA, 70°; FOV, 320 × 320 × 125 mm 3 ; acquisition matrix, 224 × 224 × 23; spatial resolution, 1.4 × 1.4 × 4 to 5 mm; reconstruction resolution, 0.6 × 0.6 × 2 to 2.5 mm).
Image analysis
Data were analyzed using a commercial workstation (Extend MR WorkSpace, version 2.3.6.3, Philips Healthcare). To determine LV mass, end-diastolic epi-and endocardial LV borders were manually traced on the short axis dataset. LV mass was calculated as the sum of the myocardial volume multiplied by the specific gravity (1.05 g/mL) of myocardial tissue [18] . Left atrial transverse dimensions were measured in the end-systolic phases using 4 chamber view. Short-axis slices of native T 1 mapping images were analyzed using custom software (MediaCare, Boston, Massachusetts). After manually contouring endocardial and epicardial LV borders, the LV was divided into 6 segments for base and mid slices, 4 segments for apical slice using the anterior right ventricular-LV insertion point as reference. The 16 segment model was used to compare the native T 1 time in each segment. Motion correction was performed using the Adaptive Registration of varying contrast-weighted images for improved tissue characterization (ARC-TIC) approach for both T 1 mapping [19] . To evaluate inter-observer reproducibility, measurements of native T 1 time from 10 AF patients and 10 normal subjects were independently taken by two observers. One of the two observers measured native T 1 time twice to assess intraobserver reproducibility. Visual assessment was performed to evaluate presence or absence of LV myocardial scar on LGE MRI by two independent observers.
Procedure of PVI
The electrophysiology procedure was performed by a femoral venous approach. A decapolar catheter was positioned in the coronary sinus and a second catheter was placed in the right atrium. Transseptal punctures were performed to obtain left atrial access. Following transseptal puncture, patients received intravenous heparin to maintain a serum activated clotting time N 250 msec. Three-dimensional electroanatomic mapping of the left atrium and PV was performed using a non-irrigated 4 or 8 mm tip NaviStar™ catheter (Biosense Webster) and CARTO™ (Biosense Webster) and/or EnSite NavX™ (Endocardial Solutions) recording systems. Ablation was performed for 20-60 s with a target temperature of 52°C. All PV were routinely isolated for all patients.
Clinical follow up
Follow up information was obtained from online medical record. Early AF recurrence was defined as AF occurring within 3 months after PVI. Late AF recurrence was defined as AF occurring between 3 months and 12 months after PVI [20] [21] [22] . AF recurrence was confirmed by either ECG or cardiac monitoring (remote implanted loop recorder). Complete follow-up was obtained from all patients.
Statistical analysis
Data were analyzed using SPSS software (version 17.0, SPSS, Inc., Chicago, IL, USA) and MedCalc for Windows (version 14.8.1, MedCalc Software, Ostend, Belgium). Continuous values are presented as means ± standard deviation (SD). Categorical values are expressed as number (%). Normality was determined by the Shapiro-Wilk test. Differences between AF patients and control subjects were evaluated using an unpaired t-test for normally distributed variables, and the Mann-Whitney U test for skewed variables. Bland and Altman plot [23] , coefficient of variation, intraclass correlation coefficient (ICC) were used to assess intra-and inter-observer reproducibility for measuring native T 1 time. Repeatability coefficients were calculated as 1.96 times the SD of the differences on the Bland-Altman plots. The differences of native T 1 time between 3 slices (base, mid and apex) were assessed using one way analysis of variance with Tukey's correction. Elevated myocardial T 1 time was defined as N 1082 msec, which was 2SD of native T 1 time in healthy control subjects. We calculated the cumulative incidence of AF recurrence after PVI using the Kaplan-Meier method and compare the two groups with a log-rank test (elevated LV T 1 time group (n = 31) vs non-elevated LV T 1 time group (n = 19)).
Multivariate Cox proportional hazards model was used to estimate the hazard ratio (HR) for recurrence of AF and reported with 95% confidence interval (CI). A P value b0.05 was considered statistically significant. Table 1 summarizes the clinical characteristics of the AF patients and control subjects. AF patients were heavier (p = 0.009) and with greater CHA2DS2-VASc score (p = 0.011). Incidence of hypertension (p = 0.046) and dyslipidemia (p = 0.028) were higher in AF patients. There was no difference in age, gender, systolic blood pressure, diastolic blood pressure, heart rate or the incidence of diabetes mellitus or current smoking. The duration of AF was defined as the time between initial AF confirmed by an electrocardiogram and MRI acquisition date. Table 2 summarizes cardiac MRI anatomic measures for the two groups. There were no significant difference in LV ejection fraction, end-diastolic volume, end-systolic volume or mass. Left atrial dimension was significantly higher in AF patients (p = 0.018). No LV LGE was observed in any subjects. recurrence (1042 ± 20 msec vs 1084 ± 45 msec, p = 0.055). Table 3 summarizes myocardial native T 1 time for each slice. Native T 1 time was elevated in all 3 slices in AF patients compared to normal subjects.
Results
Patients' characteristics
Cardiac MRI findings
Clinical follow-up
During a median follow-up duration of 326 days (range: 4-691 days), 18 of 50 (36%) AF patients experienced recurrence of AF after PVI (16 recurrences for patients with elevated LV T 1 (N1082 msec), 2 recurrences for patients with non-elevated LV T 1 (≤1082 msec)). Fig. 3 illustrated Kaplan Meier event free survival curve for AF recurrence after PVI. Significant difference was observed between AF patients with elevated LV native T 1 time and AF patients with non-elevated LV native T 1 time both in late AF recurrence (p = 0.030 by log-rank test) and in early and late AF recurrence (p = 0.006 by log-rank test). Table 4 shows the results of multivariate Cox proportional hazard analysis for AF recurrence after PVI. Multivariate analysis demonstrated that native LV T 1 time N 1082 msec is an independent and significant predictor of AF recurrence (hazard ratio: 6.53, 95%CI: 1.25-34.3, p = 0.009)
Reproducibility for measurement of native T 1 time
The results of reproducibility for native T 1 time measurements were summarized in Table 5 . Both in AF patients and control subjects, high reproducibility of native T 1 time measurements were observed for intraobserver reproducibility and inter-observer reproducibility.
Discussion
In this prospective study of consecutive AF patients referred for MRI prior to PVI, we identified elevated native T 1 time in AF patients as compared with control subjects. To the best of our knowledge, this is the first investigation to examine native T 1 time in AF patients by using the MOLLI sequence. Furthermore, we found the significant difference of AF recurrence after PVI between patients with elevated LV T 1 time and patients with non-elevated LV T 1 time, suggesting that native LV T 1 time might be useful for the risk stratification for AF recurrence after PVI in paroxysmal AF patients.
Diffuse left ventricular myocardial abnormality in AF patients detected by post-contrast and native T 1 mapping
Several studies have demonstrated the clinical utility of postcontrast T 1 mapping for the detection of diffuse myocardial abnormality in AF patients. Ling et al. showed that post-contrast T 1 mapping can identify diffuse LV fibrosis in AF patients [24] . This report provided new insight into association between AF and adverse LV remodeling. Neilan et al. revealed that extra cellular volume quantification of LV myocardium is an independent predictor of AF recurrence in hypertensive AF patients who underwent PVI [20] . McLellan et al. demonstrated a shorter post-contrast T 1 time of LV myocardium in patients with recurrent AF as compared to those without AF recurrence; post-contrast T 1 time is an independent predictor of AF recurrence [25] . These reports showed the pathophysiological link between LV myocardial fibrosis detected by post contrast T 1 mapping and atrial fibrillation. In the current study, we measured the LV native (non-contrast) myocardial T 1 time in AF patients undergoing PVI and found a significant difference between AF patients and control subjects. Although the difference of native T 1 time between AF patients and healthy controls was statistically significant, comparison of individual native T 1 time showed substantial overlap between AF patients and healthy controls (13 of 50 (26%) AF patients were less than native T 1 time of 1062 msec, which is maximum native T 1 time of healthy subjects), suggesting that native T 1 time might not be able to differentiate AF patients from healthy controls in about one fourth of the AF population. However, overlap of native T 1 time was small between healthy control and AF patients with recurrence (only 2 of 18 patients, Fig. 2 ). Important finding of this study was that the elevated native T 1 time was an independent and significant predictor of AF recurrence after PVI. These results indicated that LV native T 1 time might be useful as a possible surrogate marker to detect highrisk AF patients who are going to develop AF recurrence after PVI in near future, rather than an isolated marker to differentiate abnormal LV myocardium of AF patient and healthy LV myocardium of normal subjects.
Possible mechanism of elevated native T 1 time in AF patients
AF is known to be associated with various pathophysiologic disorders of cardiovascular system, including endothelial dysfunction [26] [27] [28] [29] [30] , inflammation and oxidative stress [31] [32] [33] , and atherosclerosis [34] [35] [36] . Freestone et al. demonstrated that endothelial dysfunction evaluated by flow-mediated dilatation is present in AF patients [26] . Table 3 Native myocardial T 1 time in each slice levels. Significant difference of LV native T 1 time was found between healthy control and AF patients with recurrence, between healthy controls and all AF patients, between AF patients with recurrence and AF patients without recurrence. However, no difference was found between healthy controls and AF without recurrence.
Lim et al. showed that catheter ablation and successful maintenance of sinus rhythm leads to a decrease in platelet activation and an improvement in endothelial function [30] . In addition, Li et al. revealed that inflammatory biomarkers such as Interleukin (IL)-6, IL-8, IL-10, tumor necrosis factors-alpha, monocyte chemoattractant protein 1, vascular endothelial growth factor, and N-terminal pro-brain natriuretic peptide were elevated in AF patients [31] . Another possible mechanism for elevated T 1 time is myocardial edema. Previous studies showed that T 1 time is substantially increased in acute myocardial edema in animal [37] and human studies [38] . Ferreira et al. showed that native T 1 mapping has a higher sensitivity compared with T 2 weighted image and LGE image for detecting acute myocarditis [38] [39] [40] . Elevated native T 1 time might be explained by myocardial edema, which could be related to high inflammatory activity in AF patients [41] . Although the evidence which clearly explains a mechanism of diffuse LV myocardial abnormality in AF patients is lacking, these cardiovascular pathophysiologic abnormalities may be associated with elevation of native T 1 time observed in the current study.
Clinical implication
Our AF population did not have LV systolic dysfunction on cine MRI and myocardial enhancement on LGE MRI in any study subjects. However, native T 1 time was significantly elevated in AF patients and elevated native T 1 time could predict future AF recurrence after PVI. This result was similar to the results of previous studies using post contrast T1 mapping images. However, the strong point of this study was that non-contrast (native) T 1 mapping could assess myocardial T 1 time even for AF patients with renal dysfunction at a high risk of nephrogenic systemic fibrosis [42] . Recent studies demonstrated the clinical utility of cardiac MRI and CT for AF ablation. Ang R. et al. showed that pulmonary vein measurements on pre-procedural CT/MR imaging can predict difficult PVI and phrenic nerve injury during cryoballoon ablation [43] . Kim et al. reported that pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation, but not paroxysmal atrial fibrillation [44] . Another study by Costa FM et al. revealed that left atrial volume is more important than the type of atrial fibrillation in predicting the long-term success of catheter ablation [45] . In the current study, the follow up duration for AF recurrence was relatively short, therefore, further study is necessary to investigate whether LV native T 1 time is useful to predict AF occurrence in long term follow up period after PVI.
Study limitation
Our study has several limitations. First, this is single center study of a relatively small population of AF patients all referred for PVI. Second, we did not performed endomyocardial biopsy to confirm the presence of myocardial fibrosis. Third, although LGE MRI showed no myocardial infarction, we did not perform X-ray coronary angiography or computed tomography angiography to exclude coronary artery disease, which is common in this population. Forth, not all the AF patients and healthy control had implantable loop recorders. Therefore, asymptomatic AF recurrence might be missed. Fig. 3 . Kaplan Meier event free survival curve for AF recurrence after pulmonary vein isolation. AF recurrence rate was significantly higher in AF patients with native T 1 time N 1082 msec than those with ≤1082 msec both in late recurrence (p = 0.030 by log rank test) and in early and late recurrence (p = 0.006).
Conclusion
Native LV myocardial T 1 time is increased in AF patients with preserved LV function referred for PVI. Native T 1 time is an independent predictor of recurrence of AF after PVI in patients with paroxysmal AF. These result suggested that LV native T 1 time might be useful for the risk stratification to detect high risk AF patients for AF recurrence after PVI.
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